SCHEMBL892963

SCHEMBL892963

OCCOC(OCCO)(OCCO)OC(OCCO)(OCCO)OCCO

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5158873 0.75 TSHR (0.35) TSHRMAPK1MEN1KMT2AALDH1A1
SCHEMBL3091156 0.69 TSHR (0.34) TSHRMAPK1
SCHEMBL5160043 0.69 TSHR (0.54) TSHRMAPK1MEN1KMT2AALDH1A1
SCHEMBL27455897 0.69
SCHEMBL1149050 0.67
SCHEMBL6428112 0.67 TSHR (0.39) TSHRMAPK1MEN1KMT2AALDH1A1
SCHEMBL10987435 0.67 ALDH1A1 (0.45) TSHRMAPK1MEN1KMT2AALDH1A1
SCHEMBL25742526 0.67 TSHR (0.39) TSHRMAPK1MEN1KMT2AALDH1A1
SCHEMBL566203 0.67
SCHEMBL8465970 0.67 TSHR (0.39) TSHRMAPK1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230221641-A1 HARDMASK COMPOSITION, HARDMASK LAYER, AND METHOD OF FORMING PATTERNS SAMSUNG SDI CO., LTD. (KR) 2023-07-13 US claimed
US-11932715-B2 Hardmask composition and method of forming patterns SAMSUNG SDI CO., LTD. (KR) 2024-03-19 US disclosed
US-20220195082-A1 HARDMASK COMPOSITION AND METHOD OF FORMING PATTERNS SAMSUNG SDI CO., LTD. (KR) 2022-06-23 US disclosed
EP-3956376-A1 STABLE SILANE MODIFIED POLYMER COMPOSITION AND METHOD Momentive Performance Materials Inc. (US) 2022-02-23 EP disclosed
CN-113387969-A Establishment of customizable proline structure-based fluorescent probe platform 南开大学 2021-09-14 CN disclosed
WO-2020214935-A1 STABILE SILANE MODIFIED POLYMER COMPOSITION AND METHOD MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2020-10-22 WO disclosed
US-20200332052-A1 STABILE SILANE MODIFIED POLYMER COMPOSITION AND METHOD MOMENTIVE PERFORMANCE MATERIALS INC. 2020-10-22 US disclosed
US-10759934-B2 Thermotropic polymers QUARZWERKE GMBH (DE) 2020-09-01 US disclosed
EP-3494162-B1 NON-TIN CATALYST FOR CURING ALKOXYSILYL-CONTAINING POLYMER MOMENTIVE PERFORMANCE MAT INC (US) 2020-06-03 EP disclosed
US-10570243-B2 Non-tin catalyst for curing alkoxysilyl-containing polymer MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2020-02-25 US disclosed
US-20060263812-A1 pH dependent ion exchange material, solid substrate having the material immobilized on its surface, and method of isolating a nucleic acid using the material or the solid substrate SAMSUNG ELECTRONICS CO., LTD. (KR) 2006-11-23 US disclosed
US-20060228470-A1 No-rinse pretreatment methods and compositions GENERAL ELECTRIC COMPANY (US) 2006-10-12 US disclosed
US-20050207963-A1 One step; high functionality; maintains critical properties; polymer composite materials, molecular electronics, sensor devices WILLIAM MARSH RICE UNIVERSITY (US) 2005-09-22 US disclosed
US-20050074390-A1 One step; high functionality; maintains critical properties; polymer composite materials, molecular electronics, sensor devices WILLIAM MARSH RICE UNIVERSITY (US) 2005-04-07 US disclosed
US-20050074613-A1 One step; high functionality; maintains critical properties; polymer composite materials, molecular electronics, sensor devices WILLIAM MARSH RICE UNIVERSITY (US) 2005-04-07 US disclosed
US-20040071624-A1 One step; high functionality; maintains critical properties; polymer composite materials, molecular electronics, sensor devices NAVY, SECRETARY OF THE UNITED STATES OF AMERICA 2004-04-15 US disclosed
US-20030170173-A1 Contrast agents GE HEALTHCARE AS (NO) 2003-09-11 US disclosed
EP-1283728-A2 CONTRAST AGENTS Amersham Health AS (NO) 2003-02-19 EP disclosed
WO-2002060812-A2 PROCESS FOR DERIVATIZING CARBON NANOTUBES WITH DIAZONIUM SPECIES AND COMPOSITIONS THEREOF WILLIAM MARSH RICE UNIVERSITY (US) 2002-08-08 WO disclosed
WO-2001089584-A2 CONTRAST AGENTS AMERSHAM HEALTH AS (NO) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030170173-A1 Contrast agents GBA1, RNASE1, MAN2B1 TSHR 1980/4885MAPK1 632/4885MEN1 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.